Clinical Rheumatology

, Volume 37, Issue 1, pp 59–66 | Cite as

CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis

Original Article
  • 186 Downloads

Abstract

CD161 is used as a surrogate marker for Th17 cells, which are implicated in the pathogenesis of rheumatoid arthritis (RA). In this study, we evaluated the percentage, clinical significance, and CD98 and CD147 expression of CD4+CD161+ T cells. The potential role of CD147 and CD98 in cyclophilin A-induced chemotaxis of CD4+CD161+ T cells was analyzed. Thirty-seven RA patients, 15 paired synovial fluid (SF) of RA, and 22 healthy controls were recruited. The cell populations and surface expression of CD98 and CD147 were analyzed by flow cytometry. Spearman’s rank correlation coefficient and multiple linear regression were applied to calculate the correlations. Chemotaxis assay was used to investigate CD4+CD161+ T cell migration. We found that the percentage of CD4+CD161+ T cells and their expression of CD147 and CD98 in SF were higher than in the peripheral blood of RA patients. Percentage of SF CD4+CD161+ T cells was positively correlated with 28-Joint Disease Activity Score (DAS28). CD147 monoclonal antibody (HAb18) attenuated the chemotactic ability of CD4+CD161+ T cells. An increased CD4+CD161+ T cell percentage and expression of CD147 and CD98 were shown in RA SF. Percentage of SF CD4+CD161+ T cells can be used as a predictive marker of disease activity in RA. CD147 block significantly decreased the chemotactic index of CD4+CD161+ cells induced by cyclophilin A (CypA). These results imply that the accumulation of CD4+CD161+ T cells in SF and their high expression of CD147 may be associated with CypA-mediated chemotaxis and contribute to local inflammation in RA.

Keywords

CD147 CD4+CD161+ T cells CD98 Chemotaxis Rheumatoid arthritis 

Notes

Acknowledgements

All research materials used in this study were provided by the Institute of Rheumatism and Immunity, Department of Clinical Immunology at Xijing Hospital. This research was supported by the National Natural Science Foundation of China (No. 81401338) and was approved by the Ethical Standards Committee of Xijing Hospital (reference number: KY20163014-1). The authors received funds to covering the costs of publishing this article. The authors also wish to thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.

Compliance with ethical standards

The study was approved by the ethics committee of Xijing Hospital, and written consent was provided by the participating patients.

Disclosures

None.

References

  1. 1.
    Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL (2011) Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther 13:R126CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Miao J, Zhang K, Lv M, Li Q, Zheng Z, Han Q, Guo N, Fan C, Zhu P (2014) Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis. Scand J Rheumatol 43:194–201CrossRefPubMedGoogle Scholar
  3. 3.
    Pfeifle R, Rothe T, Ipseiz N, Scherer HU, Culemann S, Harre U, Ackermann JA, Seefried M, Kleyer A, Uderhardt S et al (2017) Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease. Nat Immunol 18:104–113CrossRefPubMedGoogle Scholar
  4. 4.
    Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, Querci V, Fambrini M, Liotta F, Levings MK et al (2010) CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 40:2174–2181CrossRefPubMedGoogle Scholar
  5. 5.
    Chalan P, Kroesen BJ, van der Geest KS, Huitema MG, Abdulahad WH, Bijzet J, Brouwer E, Boots AM (2013) Circulating CD4+CD161+ T lymphocytes are increased in seropositive arthralgia patients but decreased in patients with newly diagnosed rheumatoid arthritis. PLoS One 8:e79370CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Miao J, Zhang K, Qiu F, Li T, Lv M, Guo N, Han Q, Zhu P (2015) Percentages of CD4+CD161+ and CD4-CD8-CD161+ T cells in the synovial fluid are correlated with disease activity in rheumatoid arthritis. Mediat Inflamm 2015:563713Google Scholar
  7. 7.
    Bai Y, Huang W, Ma LT, Jiang JL, Chen ZN (2014) Importance of N-glycosylation on CD147 for its biological functions. Int J Mol Sci 15:6356–6377CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hahn JN, Kaushik DK, Yong VW (2015) The role of EMMPRIN in T cell biology and immunological diseases. J Leukoc Biol 98:33–48CrossRefPubMedGoogle Scholar
  9. 9.
    Konttinen YT, Li TF, Mandelin J, Liljestrom M, Sorsa T, Santavirta S, Virtanen I (2000) Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 43:275–280CrossRefPubMedGoogle Scholar
  10. 10.
    Damsker JM, Okwumabua I, Pushkarsky T, Arora K, Bukrinsky MI, Constant SL (2009) Targeting the chemotactic function of CD147 reduces collagen-induced arthritis. Immunology 126:55–62CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shelhamer J, Mostowski HS, Thomas CA, Strominger JL, Fauci AS (1981) Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126:1409–1414PubMedGoogle Scholar
  12. 12.
    Kim MY, Cho JY (2016) Molecular association of CD98, CD29, and CD147 critically mediates monocytic U937 cell adhesion. Korean J Physiol Pharmacol 20:515–523CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Lee YG, Lee J, Cho JY (2010) Cell-permeable ceramides act as novel regulators of U937 cell-cell adhesion mediated by CD29, CD98, and CD147. Immunobiology 215:294–303CrossRefPubMedGoogle Scholar
  14. 14.
    Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, Katz DR, Chain B (2001) The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood 98:374–382CrossRefPubMedGoogle Scholar
  15. 15.
    Wu B, Wang Y, Yang XM, Xu BQ, Feng F, Wang B, Liang Q, Li Y, Zhou Y, Jiang JL et al (2015) Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma. J Exp Clin Cancer Res 34:110CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Guo N, Zhang K, Lv M, Miao J, Chen Z, Zhu P (2015) CD147 and CD98 complex-mediated homotypic aggregation attenuates the CypA-induced chemotactic effect on Jurkat T cells. Mol Immunol 63:253–263CrossRefPubMedGoogle Scholar
  17. 17.
    Tan J, Huang Z, Guo X, Li T, Deng W (2014) Expression and significance of cyclophilin A in synovial fibroblasts from patients with rheumatoid arthritis. Zhonghua Yi Xue Za Zhi 94:1330–1333PubMedGoogle Scholar
  18. 18.
    Wang CH, Dai JY, Wang L, Jia JF, Zheng ZH, Ding J, Chen ZN, Zhu P (2011) Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes. J Cell Mol Med 15:850–860CrossRefPubMedGoogle Scholar
  19. 19.
    Wang L, Wang CH, Jia JF, Ma XK, Li Y, Zhu HB, Tang H, Chen ZN, Zhu P (2010) Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis. J Clin Immunol 30:24–33CrossRefPubMedGoogle Scholar
  20. 20.
    Damsker JM, Bukrinsky MI, Constant SL (2007) Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J Leukoc Biol 82:613–618CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CR, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588CrossRefPubMedGoogle Scholar
  22. 22.
    Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH et al (2007) Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 116:1671–1682CrossRefPubMedGoogle Scholar
  23. 23.
    Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Raskin L, Desai B, Faubion WA, de Waal MR et al (2009) Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 206:525–534CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Poggi A, Costa P, Zocchi MR, Moretta L (1997) Phenotypic and functional analysis of CD4+ NKRP1A+ human T lymphocytes. Direct evidence that the NKRP1A molecule is involved in transendothelial migration. Eur J Immunol 27:2345–2350CrossRefPubMedGoogle Scholar
  25. 25.
    Xu D, Hemler ME (2005) Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics 4:1061–1071CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219CrossRefPubMedGoogle Scholar
  27. 27.
    Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S (2009) Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 5:325–331CrossRefPubMedGoogle Scholar
  28. 28.
    Xin X, Zeng X, Gu H, Li M, Tan H, Jin Z, Hua T, Shi R, Wang H (2016) CD147/EMMPRIN overexpression and prognosis in cancer: a systematic review and meta-analysis. Sci Rep 6:32804CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Peng F, Li H, Ning Z, Yang Z, Li H, Wang Y, Chen F, Wu Y (2016) CD147 and prostate cancer: a systematic review and meta-analysis. PLoS One 11:e0163678CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V et al (2015) Prognostic indications of elevated MCT4 and CD147 across cancer types: a meta-analysis. Biomed Res Int 2015:242437CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, Luban J (2004) Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 21:189–201CrossRefPubMedGoogle Scholar
  32. 32.
    Stonehouse TJ, Woodhead VE, Herridge PS, Ashrafian H, George M, Chain BM, Katz DR (1999) Molecular characterization of U937-dependent T-cell co-stimulation. Immunology 96:35–47CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Trachtenberg A, Pushkarsky T, Heine S, Constant S, Brichacek B, Bukrinsky M (2011) The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis. BMC Res Notes 4:396CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Kim H, Kim WJ, Jeon ST, Koh EM, Cha HS, Ahn KS, Lee WH (2005) Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin Immunol 116:217–224CrossRefPubMedGoogle Scholar
  35. 35.
    Li L, He J, Zhu L, Yang Y, Jin Y, Jia R, Liu X, Liu Y, Sun X, Li Z (2015) The clinical relevance of IL-17-producing CD4+CD161+ cell and its subpopulations in primary Sjogren’s syndrome. J Immunol Res 2015:307453CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, Frosali F, Querci V, Simonini G, Barra G et al (2011) Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 63:2504–2515CrossRefPubMedGoogle Scholar
  37. 37.
    Dawar FU, Wu J, Zhao L, Khattak MN, Mei J, Lin L (2017) Updates in understanding the role of cyclophilin A in leukocyte chemotaxis. J Leukoc BiolGoogle Scholar
  38. 38.
    Takahashi T, Dejbakhsh-Jones S, Strober S (2006) Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176:211–216CrossRefPubMedGoogle Scholar
  39. 39.
    Gernez Y, Tirouvanziam R, Nguyen KD, Herzenberg LA, Krensky AM, Nadeau KC (2007) Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids. J Allergy Clin Immunol 120:1441–1448CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2017

Authors and Affiliations

  1. 1.Department of Clinical Immunology, PLA Specialized Research Institute of Rheumatology & Immunology, Xijing HospitalFourth Military Medical UniversityXi’anChina
  2. 2.Department of Hemotalogy and RheumatologyHanzhong 3201 HospitalHanzhongChina

Personalised recommendations